Reply to "A call for reporting of tumor-specific outcomes in studies of DPYD genotyping".

Autor: El Rouby N; St Elizabeth Healthcare, Edgewood, Kentucky, USA.; Department of Pharmacy Practice and Administrative Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA., Allen JD; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Muldoon M; Swedish Hospital, Part of Endeavor Health, Chicago, Illinois, USA., Beck M; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Hesse K; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Sebree N; University of Cincinnati Medical Center, Cincinnati, Ohio, USA., Yoder R; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Ritter S; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Alqahtani Z; Department of Pharmacy Practice and Administrative Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA., Grund J; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Holbrook BP; St Elizabeth Healthcare, Edgewood, Kentucky, USA.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e70008.